ABMD Share Price

Open 180.12 Change Price %
High 193.95 1 Day 13.44 7.49
Low 180.12 1 Week 0.00 0.00
Close 192.92 1 Month 19.07 10.97
Volume 800004 1 Year 82.91 75.37
52 Week High 193.95
52 Week Low 103.53
ABMD Important Levels
Resistance 2 205.74
Resistance 1 200.46
Pivot 189.00
Support 1 185.38
Support 2 180.10
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

ABIOMED, Inc. (NASDAQ: ABMD)

ABMD Technical Analysis 5
As on 31st Oct 2017 ABMD Share Price closed @ 192.92 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 135.85 & Strong Buy for SHORT-TERM with Stoploss of 163.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
ABMD Target for December
1st Target up-side 208.81
2nd Target up-side 219.94
3rd Target up-side 231.08
1st Target down-side 177.03
2nd Target down-side 165.9
3rd Target down-side 154.76
ABMD Other Details
Segment EQ
Market Capital 527299872.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.abiomed.com
ABMD Address
ABMD
22 Cherry Hill Drive
Danvers, MA 01923
United States
Phone: 978-646-1400
Fax: 978-777-8411
ABMD Latest News
Interactive Technical Analysis Chart ABIOMED, Inc. ( ABMD NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ABIOMED, Inc.
ABMD Business Profile
ABIOMED, Inc., incorporated on June 4, 1987, is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. In September 2012, the Company announced that its Impella CP product received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for partial circulatory support for up to six hours. In November 2012, the Company announced that the Impella RP received Investigational Device Exemption, or IDE, approval from the FDA for use in RECOVER RIGHT, a pivotal clinical study in the U.S. In December 2012, as part of the FDA's 515 Program Initiative, an FDA panel voted to recommend continuation of Class III status for temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category, which includes the Company's Impella products. The Company Headquarters is at 22 Cherry Hill Drive, Danvers, Massachusetts 01923.